Article Versions Notes

Kwaśnik P, Zaleska J, Link-Lenczowska D, Zawada M, Wysogląd H, Ochrem B, Bober G, Wasilewska E, Hus I, Szarejko M, et al. High Level of CD8⁺PD-1⁺ Cells in Patients with Chronic Myeloid Leukemia Who Experienced Loss of MMR after Imatinib Discontinuation. Cells. 2024; 13(8):723. https://doi.org/10.3390/cells13080723

Kwaśnik, Paulina, Joanna Zaleska, Dorota Link-Lenczowska, Magdalena Zawada, Hubert Wysogląd, Bogdan Ochrem, Grażyna Bober, Ewa Wasilewska, Iwona Hus, Monika Szarejko, and et al. 2024. "High Level of CD8⁺PD-1⁺ Cells in Patients with Chronic Myeloid Leukemia Who Experienced Loss of MMR after Imatinib Discontinuation" Cells 13, no. 8: 723. https://doi.org/10.3390/cells13080723

Kwaśnik, P., Zaleska, J., Link-Lenczowska, D., Zawada, M., Wysogląd, H., Ochrem, B., Bober, G., Wasilewska, E., Hus, I., Szarejko, M., Prejzner, W., Grzybowska-Izydorczyk, O., Klonowska-Szymczyk, A., Mędraś, E., Kiełbus, M., Sacha, T., & Giannopoulos, K. (2024). High Level of CD8⁺PD-1⁺ Cells in Patients with Chronic Myeloid Leukemia Who Experienced Loss of MMR after Imatinib Discontinuation. Cells, 13(8), 723. https://doi.org/10.3390/cells13080723